Multiorgan dysfunction precipitated by disulfiram use and posterior reversible encephalopathy syndrome with atypical presentation: a case report

References

• Bartynski, W. S., Boardman, J. F., Zeigler, Z. R., Shadduck, R. K., & Lister, J. (2006). Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR American Journal of Neuroradiology, 27(10), 2179–2190.
   PubMed Web of Science ®Google Scholar
• Bartynski, W. S., Tan, H. P., Boardman, J. F., Shapiro, R., & Marsh, J. W. (2008). Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR American Journal of Neuroradiology, 29(5), 924–930. https://doi.org/10.3174/ajnr.A0960
   PubMed Web of Science ®Google Scholar
• Bhattacharya, P. (2016). Posterior reversible encephalopathy syndrome (PRES). International Neurology, 53.
   Google Scholar
• Díaz-Ramírez, G. S., Salgado-Cifuentes, C. A., Zúñiga-Escobar, G., & Morales-Plaza, C. D. (2019). Posterior reversible leukoencephalopathy syndrome associated with psychosis: An unusual presentation. Síndrome de leucoencefalopatía posterior reversible asociado a psicosis: una presentación inusual. Neurologia (Barcelona, Spain), 34(8), 549–551. https://doi.org/10.1016/j.nrl.2016.11.013
   PubMedGoogle Scholar
• Drye, C., Bose, S., Pathireddy, S., & Aeddula, N. R. (2019). Guillain-Barre syndrome with concurrent posterior reversible encephalopathy syndrome and hyponatremia: Mere coincidence or rare coexistence. BMJ Case Reports, 12(7), e229749. https://doi.org/10.1136/bcr-2019-229749
   PubMedGoogle Scholar
• Etxeberria, A., Lonneville, S., Rutgers, M. P., & Gille, M. (2012). Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Revue Neurologique, 168(3), 283–286. https://doi.org/10.1016/j.neurol.2011.06.006
   PubMed Web of Science ®Google Scholar
• Fugate, J. E., Claassen, D. O., Cloft, H. J., Kallmes, D. F., Kozak, O. S., & Rabinstein, A. A. (2010). Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clinic Proceedings, 85(5), 427–432. https://doi.org/10.4065/mcp.2009.0590
   PubMed Web of Science ®Google Scholar
• Fugate, J. E., & Rabinstein, A. A. (2015). Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurology, 14(9), 914–925. https://doi.org/10.1016/S1474-4422(15)00111-8
   PubMed Web of Science ®Google Scholar
• Gocmen, R., Ozgen, B., & Oguz, K. K. (2007). Widening the spectrum of PRES: Series from a tertiary care center. European Journal of Radiology, 62(3), 454–459. https://doi.org/10.1016/j.ejrad.2006.12.001
   PubMed Web of Science ®Google Scholar
• Hayman, M., & Wilkins, P. A. (1956). Polyneuropathy as a complication of disulfiram therapy of alcoholism. Quarterly Journal of Studies on Alcohol, 17(4), 601–607. https://doi.org/10.15288/qjsa.1956.17.601
   PubMedGoogle Scholar
• Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J. L., & Caplan, L. R. (1996). A reversible posterior leukoencephalopathy syndrome. The New England Journal of Medicine, 334(8), 494–500. https://doi.org/10.1056/NEJM199602223340803
   PubMed Web of Science ®Google Scholar
• Keynejad, R. C., & David, A. S. (2020). Psychiatric morbidity and its prognosis in posterior reversible encephalopathy syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 32(4), 385–388. https://doi.org/10.1176/appi.neuropsych.19080184
   PubMed Web of Science ®Google Scholar
• Kulkarni, R. R., Ramdurg, S. I., & Bairy, B. K. (2014). Disulfiram-induced reversible hypertension: A prospective case series and review of the literature. Indian Journal of Psychological Medicine, 36(4), 434–438. https://doi.org/10.4103/0253-7176.140744
   PubMedGoogle Scholar
• McKinney, A. M., Short, J., Truwit, C. L., McKinney, Z. J., Kozak, O. S., SantaCruz, K. S., & Teksam, M. (2007). Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. AJR American Journal of Roentgenology, 189(4), 904–912. https://doi.org/10.2214/AJR.07.2024
   PubMed Web of Science ®Google Scholar
• Olney, R. K., & Miller, R. G. (1980). Peripheral neuropathy associated with disulfiram administration. Muscle & Nerve, 3(2), 172–175. https://doi.org/10.1002/mus.880030211
   PubMedGoogle Scholar
• Storti, B., Vedovello, M., Riva, R., Agazzi, E., Censori, B., Manara, O., Sessa, M., & Rottoli, M. R. (2020). Posterior reversible encephalopathy and Guillain-Barré syndrome: Which came first, the chicken or the egg? A review of the literature. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 41(12), 3663–3666. https://doi.org/10.1007/s10072-020-04496-1
   PubMed Web of Science ®Google Scholar
• Sudulagunta, S. R., Sodalagunta, M. B., Kumbhat, M., & Settikere Nataraju, A. (2017). Posterior reversible encephalopathy syndrome(PRES). Oxford Medical Case Reports, 2017(4), omx011. https://doi.org/10.1093/omcr/omx011
   PubMedGoogle Scholar
• Viola-Rhenals, M., Patel, K. R., Jaimes-Santamaria, L., Wu, G., Liu, J., & Dou, Q. P. (2018). Recent advances in antabuse (Disulfiram): The importance of its metal-binding ability to its anticancer activity. Current Medicinal Chemistry, 25(4), 506–524. https://doi.org/10.2174/0929867324666171023161121
   PubMed Web of Science ®Google Scholar
• Watts, T. E., Pandey, R. A., & Vancil, T. J. (2014). Fatal fulminant hepatic failure related to the use of disulfiram. The Journal of the Arkansas Medical Society, 110(13), 280–283.
   PubMedGoogle Scholar
• Xu, B., Wang, S., Li, R., Chen, K., He, L., Deng, M., Kannappan, V., Zha, J., Dong, H., & Wang, W. (2017). Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2. Cell Death & Disease, 8(5), e2797. https://doi.org/10.1038/cddis.2017.176
   PubMedGoogle Scholar
• Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V., Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011). Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. British Journal of Cancer, 104(10), 1564–1574. https://doi.org/10.1038/bjc.2011.126
   PubMed Web of Science ®Google Scholar
• Yonekura, S., Anno, T., & Kobayashi, N. (2018). Posterior reversible encephalopathy syndrome and Guillain-Barré Syndrome after head injury: Case report. Neurologia medico-chirurgica, 58(10), 453–458. https://doi.org/10.2176/nmc.cr.2018-0049
   PubMed Web of Science ®Google Scholar